, Tracking Stock Market Picks
Enter Symbol:
Tenet Healthcare Corporation (THC) [hlAlert]

up 112.39 %

Tenet Healthcare Corporation (THC) rated Outperform with price target $7 by Credit Suisse

Posted on: Wednesday,  Nov 4, 2009  9:25 AM ET by Credit Suisse

Credit Suisse rated Outperform Tenet Healthcare Corporation (NYSE: THC) on 11/04/2009. Previously Credit Suisse rated Outperform Tenet Healthcare Corporation (NYSE: THC) on
04/25/2008., when the stock price was $23.40. Since then, Tenet Healthcare Corporation has gained 112.39% as of 01/21/2016's recent price of $49.70.
If you would have followed the previous Credit Suisse's recommendation on THC, you would have gained 112.39% of your investment in 2827 days.

Tenet Healthcare Corporation (Tenet) is an investor-owned health care services company, whose subsidiaries and affiliates principally operate general hospitals and related health care facilities. The Company?s operations are conducted through its subsidiaries. As of December 31, 2008, Tenet?s subsidiaries operated 53 general hospitals, a cancer hospital and a critical access hospital, with a combined total of 14,352 licensed beds, serving urban and rural communities in 12 states. Of those general hospitals, 45 were owned by the Company?s subsidiaries and eight were owned by third parties and leased by its subsidiaries (including one hospital Tenet owned located on land leased from a third party). In August 2008, the Company announced that it has completed the previously disclosed sale of its entire interest in Broadlane, Inc. to TowerBrook Capital Partners L.P. In November 2008, Tenet announced the formation of a wholly owned operating subsidiary, Conifer Health Solutions, Inc.

Excellence in equity and fixed income research is a hallmark of Credit Suisse. Globally, our equity research analysts provide in-depth coverage of over 2,500 companies and engage in a knowledge-sharing, value added culture that has yielded the most insightful product for our customers and tremendous competitive results. Additionally, Credit Suisse's powerful macro-economic and debt strategy teams integrate the bank's comprehensive company research with keen market perspectives of the ever-shifting investment terrain.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
11/4/2009 9:25 AM Buy
21.64 28.00
as of 12/31/2009
1 Week up  19.21 %
1 Month up  47.25 %
3 Months up  13.94 %
1 YTD up  482.60 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/23/2008 8:25 AM Buy
23.60 28.00
4/25/2008 8:25 AM Buy
23.40 32.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy